Comparing Clever Leaves (NASDAQ:CLVR) & Biofrontera (NASDAQ:BFRI)


Clever Leaves (NASDAQ:CLVRGet Rating) and Biofrontera (NASDAQ:BFRIGet Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, earnings and valuation.

Analyst Recommendations

This is a summary of recent ratings and price targets for Clever Leaves and Biofrontera, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clever Leaves 0 2 1 0 2.33
Biofrontera 0 0 1 0 3.00

Clever Leaves currently has a consensus price target of $2.85, indicating a potential upside of 738.24%. Biofrontera has a consensus price target of $7.00, indicating a potential upside of 1,076.67%. Given Biofrontera’s stronger consensus rating and higher possible upside, analysts plainly believe Biofrontera is more favorable than Clever Leaves.

Insider and Institutional Ownership

17.3% of Clever Leaves shares are held by institutional investors. Comparatively, 6.8% of Biofrontera shares are held by institutional investors. 8.8% of Clever Leaves shares are held by company insiders. Comparatively, 0.6% of Biofrontera shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Earnings and Valuation

This table compares Clever Leaves and Biofrontera’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Clever Leaves $17.80 million 0.85 -$66.17 million ($1.75) -0.19
Biofrontera $28.67 million 0.55 -$640,000.00 $0.02 29.76

Biofrontera has higher revenue and earnings than Clever Leaves. Clever Leaves is trading at a lower price-to-earnings ratio than Biofrontera, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Clever Leaves has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Comparatively, Biofrontera has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500.

Profitability

This table compares Clever Leaves and Biofrontera’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Clever Leaves -371.71% -51.72% -39.12%
Biofrontera -2.23% -86.13% -33.47%

Summary

Biofrontera beats Clever Leaves on 8 of the 13 factors compared between the two stocks.

About Clever Leaves

(Get Rating)

Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.

About Biofrontera

(Get Rating)

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was founded in 1997 and is headquartered in Woburn, Massachusetts.



Receive News & Ratings for Clever Leaves Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Clever Leaves and related companies with MarketBeat.com’s FREE daily email newsletter.

Read more here: Source link

Leave a Reply

Your email address will not be published. Required fields are marked *